2022-11-23
ENA-FIRST-PUBLIC
2022-11-23
ENA-LAST-UPDATE
GSM5773163
External Id
SAMN24657271
External Id
2022-11-23T01:43:25Z
INSDC first public
2022-11-23T01:43:25Z
INSDC last update
public
INSDC status
SRS11508346
SRA accession
GSM5773163
Submitter Id
NCBI
broker name
PBMC cells
cell type
human
common name
male
gender
Europe Am
genotype
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
Enriched CD3+, CD14+/CD16+, and CD19+ cells from a 34-year-old with celiac disease and atopic dermatitis being treated with Dupilumab (a 600 mg loading dose 30 days after vaccination and were then maintained at 300 mg q.2 weeks till the analysis)
source_name
34-year-old with celiac disease and atopic dermatitis being treated with Dupilumab (a 600 mg loading dose 30 days after vaccination and were then maintained at 300 mg q.2 weeks till the analysis)
subject status
heparinized blood
tissue
AD2(+)_single_cell_RNAseq
title